Seattle, WA, United States of America

Marja S Huhta

This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Cyt Immune Sciences, Inc., Cytlmmune Sciences, Inc.. Active years: 2011-2013.

USPTO Granted Patents = 2 

% Patents Active = 100.0


 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2011-2013

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Marja S Huhta: Innovator in Antibody Generation

Introduction

Marja S Huhta is a prominent inventor based in Seattle, WA, known for her significant contributions to the field of immunology. With a focus on generating antibodies, she has developed innovative methods and compositions that enhance the immune response.

Latest Patents

Marja holds two patents related to compositions and methods for generating antibodies. Her inventions involve the efficient presentation of antigens to the immune system, resulting in the production of species-specific antibodies in vitro. These compositions typically include one or more antigenic components combined with colloidal metals, and may also incorporate derivatized polyethylene glycol (PEG) or other agents. Additionally, her patents introduce novel cytokine cocktails designed to generate desired antibodies.

Career Highlights

Throughout her career, Marja has worked with notable companies such as Cyt Immune Sciences, Inc. and Cytlmmune Sciences, Inc. Her work has significantly advanced the understanding and application of antibody generation techniques.

Collaborations

Marja has collaborated with esteemed colleagues, including Giulio F Paciotti and Ramadevi Raghunandan, contributing to her innovative research and development efforts.

Conclusion

Marja S Huhta's work in antibody generation showcases her dedication to advancing immunological research. Her patents and collaborations reflect her commitment to innovation in the field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…